Table 2.
High-contrast logMAR acuity of subjects in the KCE cohort and VAE cohort under unaided, spectacle-corrected and RGP CL-corrected viewing conditions.
Subject number | Unaided viewing | Spectacle corrected viewing | RGP CL corrected viewing | |||
---|---|---|---|---|---|---|
KCE cohort | ||||||
Right eye | Left eye | Right eye | Left eye | Right eye | Left eye | |
1 | 1.06 | 0.62 | 0.38 | 0.16 | 0.10 | 0.08 |
2 | 0.44 | 0.54 | −0.08 | 0.32 | −0.10 | 0.02 |
3 | 0.70 | 0.40 | 0.30 | 0.18 | 0.10 | 0.00 |
4 | 0.22 | 0.86 | 0.20 | 0.28 | 0.14 | 0.06 |
5 | 0.60 | 0.20 | 0.20 | 0.10 | 0.12 | 0.00 |
6 | 1.12 | 0.26 | 0.28 | 0.34 | 0.12 | −0.02 |
7 | 0.86 | 0.50 | 0.40 | 0.08 | 0.00 | −0.02 |
8 | 0.96 | 0.90 | 0.18 | 0.10 | −0.06 | 0.00 |
9 | 0.22 | 0.42 | 0.04 | 0.12 | 0.04 | 0.00 |
10 | 0.44 | 0.14 | 0.56 | 0.02 | 0.04 | −0.10 |
11 | 0.30 | 0.34 | 0.10 | 0.06 | 0.00 | 0.00 |
12 | 0.90 | 0.56 | 0.70 | 0.24 | 0.18 | 0.10 |
Median (IQR) | 0.65 (0.41–0.92) | 0.46 (0.32–0.58) | 0.24 (0.16–0.39) | 0.14 (0.10–0.25) | 0.07 (0.00–0.12) | 0.00 (−0.01–0.03) |
VAE cohort | ||||||
Ectatic eye | Non-ectatic eye | Ectatic eye | Non-ectatic eye | Ectatic eye | Non-ectatic eye | |
1 | 0.22 | −0.08 | 0.18 | 0.04 | 0.02 | — |
2 | 0.52 | 0.52 | 0.48 | 0.02 | 0.14 | — |
3 | 0.44 | 0.02 | 0.48 | −0.06 | 0.00 | — |
4 | 0.52 | 0.42 | 0.06 | −0.04 | 0.02 | — |
5 | 1.16 | 0.06 | 0.40 | −0.06 | 0.00 | — |
6 | 0.46 | 0.02 | 0.20 | −0.08 | 0.04 | — |
7 | 0.60 | 0.36 | 0.12 | −0.06 | 0.04 | — |
8 | 0.58 | 0.30 | 0.22 | 0.00 | 0.06 | — |
9 | 0.22 | 0.02 | 0.00 | −0.12 | 0.04 | — |
Median (IQR) | 0.52 (0.44–0.58) | 0.06 (0.02–0.36) | 0.20 (0.12–0.40) | −0.06 (−0.06–0.00) | 0.04 (0.02–0.04) | — |
LogMAR acuity was obtained as a part of patient’s routine eye examination using a computerized acuity measurement system (Complog®, Clinical Vision Measurement Systems Ltd, UK)40.